Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M T Candel"'
Autor:
A. Sole-Calvo, B. Massuti, Alfredo Carrato, Carlos Camps, A. Villar, J. Aranda, M. Martín, Joan Albanell, A. Casado, Eduardo Díaz-Rubio, Roberto González, B. Munarriz, M. T. Candel, J. Lizon, J. Campbell
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 14(6)
Background The purpose of this study was to determine the relative efficacy of doxorubicin versus methotrexate in combination with intravenous cyclophosphamide and 5-fluorouracil (FAC versus CMF) as adjuvant chemotherapy for operable breast cancer. P
Autor:
A. Villar-Grimalt, B. Massuti, M T Candel, A Frau, R Goedkoop, J Lizón, B Sánchez, B Gorostidi
Publikováno v:
British Journal of Cancer
This study compared the efficacy and safety of 5-fluorouracil (5-FU) monotherapy to that of 5-FU combined with natural human interferon-β (IFN-β) in patients with unresectable, advanced colorectal carcinoma. Forty-nine chemotherapy-naive patients w
Autor:
A, Villar-Grimalt, E, Aranda, B, Massutí, J, Belón, A, Antón, J M, Jimeno, M T, Candel, M L, García de Paredes, E, Colajori
Publikováno v:
Tumori. 80(2)
To evaluate a new anthracycline 4'-iodo-4'-deoxydoxorubicin (I-DOX) in patients with measurable advanced colorectal adenocarcinoma in a phase II study.We investigated therapeutic activity and toxicities associated with repeated courses of I-DOX 80 mg
Autor:
A, Villar, M T, Candel, F, Delgado, J, García, I, Melchor, A, García, J, Aguiló, F, Asencio, V, Viciano, I, González
Publikováno v:
Medicina clinica. 98(8)
To observe whether patients with breast cancer of an epithelial strain consult physician with a less advanced disease, the patients attended by the Valencian Interhospital Group were studied between January 1981 and December 1990.The same diagnosis o
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 2(4)
Publikováno v:
Medicina clinica. 93(6)